From: healthline.com Diet can be a key factor during breast cancer treatment. A nutritious diet is linked to reduced inflammation and a strengthened immune system. Your diet plays an important role in managing your health during breast cancer treatment. The food you eat can help boost your immune system, reduce inflammation, and more. Your diet can also help you manage …
Black Women Have Higher Risk for Death in BC Subtypes
From: medscape.com TOPLINE: Black women in the United States have higher breast cancer (BC) mortality rates than White women across tumor subtypes. The greatest disparity in BC-specific survival was observed in those with hormone receptor-positive (HR+), human epidermal growth factor 2–negative (HER2−) tumors, with Black women having a 50% higher risk for death. METHODOLOGY: US Black women have a 40% …
Researchers Uncover Key Actor in Spread of Breast Cancer to the Brain
By: Rob Levy From: dana-farber.org Dana-Farber researchers have identified a key mechanism involving the KMT2C and KMT2D genes that drives breast cancer metastasis to the brain. The study highlights the role of the KDM6A protein in promoting this spread, particularly in patients with triple-negative breast cancer. This discovery opens the door to potential new treatments targeting KDM6A to prevent brain …
What You Need to Know About Breast Radiation Burns
From: bezzybc.com Most people undergoing radiation therapy experience radiation burns, or sunburn-like burning and peeling. There are steps you can take to care for them, like wearing loose clothes and applying barrier creams. Radiation therapy is a powerful treatment for breast cancer, but it can come with an uncomfortable side effect: radiation burns, also known as radiation dermatitis. Here’s what …
Breast Cancer Awareness: About Sleep
View PostExtended estrogen suppression treatment found safe for postmenopausal breast cancer patients
Source:Elsevier From: news-medical.net New evidence shows that extended estrogen suppression treatment using an aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe; it does not increase the risk of coronary artery calcification, a sign of active coronary atherosclerosis, as some prior studies had indicated. An article in the Canadian Journal of Cardiology, published by Elsevier, details the findings from …
Breast, Ovarian Cancer Risks of RAD51C Variants Assessed Systematically
From: insideprecisionmedicine.com Researchers from the Wellcome Sanger Institute and their collaborators investigated RAD51C and uncovered over 3,000 harmful genetic changes that could potentially disrupt its function and increase cancer risk in breast and ovarian cancer. The findings are published in the journal Cell and paves the way for better risk assessment and more personalized care. By mapping the protein structure, …
Starting Mammography at Age 40 May Backfire Due to False Positives
By: Kenneth W. Lin, MD, MPH From: medscape.com Hi, everyone. I’m Dr Kenny Lin. I am a family physician and associate director of the Lancaster General Hospital Family Medicine Residency, and I blog at Common Sense Family Doctor. Earlier this year, I wrote a Medscape commentary to explain my disagreement with the US Preventive Services Task Force (USPSTF)’s updated recommendation …
Sodium in tumor microenvironments found to heighten T-cell activation, suggesting new cancer treatment avenues
By: Pooja Toshniwal Paharia From: news-medical.net In a recent study published in Nature Immunology, researchers investigated the direct influence of sodium (Na+) ions on the cytotoxic cluster of differentiation 8 (CD8)-expressing T cells and hence on antitumor cytotoxicity. Background The metabolic status of cytotoxic T cells or lymphocytes controls antitumor immunity. These cells are sensitive to the tumor microenvironment (TME). …
Quality-of-life outcomes reported from trial comparing whole-breast and partial-breast irradiation post-surgery
By: NRG Oncology From: medicalxpress.com The NRG Oncology (NRG)/NSABP B-39/RTOG 0413 clinical trial compared whole-breast irradiation (WBI) to accelerated partial-breast irradiation (APBI) and determined that APBI was not statistically equivalent to WBI in local tumor control. The secondary outcome for the trial was Quality-of-life (QOL). The research is published in the JNCI: Journal of the National Cancer Institute. The study …